External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience EAN 2023
Roche and Genentech at

EAN 2023

July 01 - July 04
Budapest, Hungary
ean.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Aug 3 / Roche
Brain Health: Buzzword or the Future for Neurologists?
Presentation slides from an interactive symposium in which a mulitidisciplinary faculty discuss the importance of preserving and improving brain health for all, providing the patient perspective, clinical perspectives in the context of next-generation memory clinics and specialist clinics for multiple sclerosis, as well as discussing socioeconomic factors and collaborations driving large-scale change.
Neuroscience Alzheimer Disease Multiple Sclerosis EAN-2023

Sign up or login to unlock the full suite of MEDICALLY features
Aug 3 / Roche
Unearthing the Socio-economic Burden of Neurological Disorders to Drive Large-scale Innovation and Investment
An interactive symposium in which a mulitidisciplinary faculty discuss the importance of preserving and improving brain health for all, providing the patient perspective, clinical perspectives in the context of next-generation memory clinics and specialist clinics for multiple sclerosis, as well as discussing socioeconomic factors and collaborations driving large-scale change (Presentation 4: Harris Eyre).
Neuroscience Alzheimer Disease Multiple Sclerosis EAN-2023

Sign up or login to unlock the full suite of MEDICALLY features
Aug 3 / Roche
Role of the Patient Community in Brain Health: From Understanding to Action
An interactive symposium in which a mulitidisciplinary faculty discuss the importance of preserving and improving brain health for all, providing the patient perspective, clinical perspectives in the context of next-generation memory clinics and specialist clinics for multiple sclerosis, as well as discussing socioeconomic factors and collaborations driving large-scale change (Presentation 1: Orla Galvin).
Neuroscience Alzheimer Disease Multiple Sclerosis EAN-2023
02:00 PM
Duration 5mins ePoster area
FIREFISH Parts 1 and 2: 48-month efficacy and safety of risdiplam▼ in Type 1 spinal muscular atrophy (SMA)
M Mazurkiewicz-Beldzinska, G Baranello, O Boespflug-Tanguy, JW Day, N Deconinck, A Klein, R Masson, E Mercuri, K Rose, L Servais, D Vlodavets, H Xiong, E Zanoteli, M El-Khairi, M Gerber, K Gorni, H Kletzl, L Palfreeman, A Dodman, BT Darras
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins ePoster area
SUNFISH Parts 1 and 2: 4-year efficacy and safety data of risdiplam▼ in Types 2 and 3 spinal muscular atrophy (SMA)
A Kostera-Pruszczyk, JW Day, N Deconinck, ES Mazzone, A Nascimento, M Oskoui, K Saito, C Vuillerot, G Baranello, O Boespflug-Tanguy, N Goemans, J Kirschner, L Servais, J Braid, M Gerber, K Gorni, C Martin, WY Yeung, RS Scalco, E Mercuri
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.